- Home
- CAI vs ICL Comparison
CAI vs ICL Comparison
Compare CAI & ICL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAI
- ICL
- Stock Information
- Founded
- CAI 2008
- ICL 1968
- Country
- CAI United States
- ICL Israel
- Employees
- CAI N/A
- ICL N/A
- Industry
- CAI Medical Specialities
- ICL Agricultural Chemicals
- Sector
- CAI Health Care
- ICL Industrials
- Exchange
- CAI Nasdaq
- ICL Nasdaq
- Market Cap
- CAI 9.4B
- ICL 8.3B
- IPO Year
- CAI 2025
- ICL N/A
- Fundamental
- Price
- CAI $32.94
- ICL $6.09
- Analyst Decision
- CAI Strong Buy
- ICL Hold
- Analyst Count
- CAI 6
- ICL 3
- Target Price
- CAI $35.50
- ICL $6.57
- AVG Volume (30 Days)
- CAI 518.8K
- ICL 587.8K
- Earning Date
- CAI 11-12-2025
- ICL 11-10-2025
- Dividend Yield
- CAI N/A
- ICL 3.17%
- EPS Growth
- CAI N/A
- ICL N/A
- EPS
- CAI N/A
- ICL 0.28
- Revenue
- CAI $533,847,000.00
- ICL $6,953,000,000.00
- Revenue This Year
- CAI $64.66
- ICL $6.15
- Revenue Next Year
- CAI $45.81
- ICL $5.21
- P/E Ratio
- CAI N/A
- ICL $21.59
- Revenue Growth
- CAI 106.53
- ICL N/A
- 52 Week Low
- CAI $25.40
- ICL $3.79
- 52 Week High
- CAI $42.50
- ICL $7.35
- Technical
- Relative Strength Index (RSI)
- CAI N/A
- ICL 41.73
- Support Level
- CAI N/A
- ICL $6.04
- Resistance Level
- CAI N/A
- ICL $6.16
- Average True Range (ATR)
- CAI 0.00
- ICL 0.09
- MACD
- CAI 0.00
- ICL 0.00
- Stochastic Oscillator
- CAI 0.00
- ICL 30.00
About CAI Caris Life Sciences Inc. Common Stock
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
About ICL ICL Group Ltd.
ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and growing solutions. These segments all contribute to the company's development of agriculture, food, and engineered material products and services. Maximum revenue is generated from its phosphate solutions segment which uses phosphate commodity products, such as phosphate rock and fertilizer-grade phosphoric acid (green phosphoric acid), to produce specialty products. This segment also produces and markets phosphate-based fertilizers. Geographically, the company generates maximum revenue from Brazil followed by, the United States of America, China, United Kingdom, Germany, Spain, Israel, France, India, Netherlands, and other countries.